Biotricity, Inc. (BTCY)
OTCMKTS
· Delayed Price · Currency is USD
0.4600
+0.0100 (2.22%)
Apr 25, 2025, 3:56 PM EDT
Biotricity Revenue
Biotricity had revenue of $3.62M in the quarter ending December 31, 2024, with 21.73% growth. This brings the company's revenue in the last twelve months to $13.27M, up 14.09% year-over-year. In the fiscal year ending March 31, 2024, Biotricity had annual revenue of $12.06M with 25.15% growth.
Revenue (ttm)
13.27M
Revenue Growth
+14.09%
P/S Ratio
0.86
Revenue / Employee
241.20K
Employees
55
Market Cap
11.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 12.06M | 2.42M | 25.15% |
Mar 31, 2023 | 9.64M | 1.99M | 26.00% |
Mar 31, 2022 | 7.65M | 4.27M | 126.02% |
Mar 31, 2021 | 3.38M | 1.97M | 138.75% |
Mar 31, 2020 | 1.42M | 1.02M | 256.03% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 20.65M |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Biotricity News
- 20 days ago - Biotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed - GlobeNewsWire
- 6 weeks ago - Biotricity expands intellectual property portfolio with 14 new patents - Seeking Alpha
- 6 weeks ago - Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management - GlobeNewsWire
- 2 months ago - Biotricity GAAP EPS of -$0.05, revenue of $3.6M - Seeking Alpha
- 2 months ago - Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025 - GlobeNewsWire
- 2 months ago - Biotricity expects to post Q3 revenue growth of 22%, cashflow breakeven - Seeking Alpha
- 2 months ago - Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11% - GlobeNewsWire
- 2 months ago - BTCY:CA - Earn Yield On Your Digital Gold - Seeking Alpha